119 related articles for article (PubMed ID: 8289204)
1. Structure-activity studies of benzimidazole-based DNA-cleaving agents. Comparison of benzimidazole, pyrrolobenzimidazole, and tetrahydropyridobenzimidazole analogues.
Skibo EB; Islam I; Heileman MJ; Schulz WG
J Med Chem; 1994 Jan; 37(1):78-92. PubMed ID: 8289204
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity studies of antitumor agents based on pyrrolo[1,2-a]benzimidazoles: new reductive alkylating DNA cleaving agents.
Islam I; Skibo EB; Dorr RT; Alberts DS
J Med Chem; 1991 Oct; 34(10):2954-61. PubMed ID: 1920349
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the cytotoxic and physical properties of aziridinyl quinone derivatives based on the pyrrolo[1,2-a]benzimidazole and pyrrolo[1,2-a]indole ring systems.
Boruah RC; Skibo EB
J Med Chem; 1994 May; 37(11):1625-31. PubMed ID: 8201596
[TBL] [Abstract][Full Text] [Related]
4. Pyrrolo[1,2-a]benzimidazole-based aziridinyl quinones. A new class of DNA cleaving agent exhibiting G and A base specificity.
Skibo EB; Schulz WG
J Med Chem; 1993 Oct; 36(21):3050-5. PubMed ID: 8230090
[TBL] [Abstract][Full Text] [Related]
5. Pyrrolobenzimidazoles linked to heterocycles and peptides. Design of DNA base pair specific phosphate hydrolyzing agents and novel cytotoxic agents.
Ghodousi A; Huang X; Cheng Z; Skibo EB
J Med Chem; 2004 Jan; 47(1):90-100. PubMed ID: 14695823
[TBL] [Abstract][Full Text] [Related]
6. Chemistry of the pyrrolo[1,2-alpha]benzimidazole antitumor agents: influence of the 7-substituent on the ability to alkylate DNA and inhibit topoisomerase II.
Zhou R; Skibo EB
J Med Chem; 1996 Oct; 39(21):4321-31. PubMed ID: 8863809
[TBL] [Abstract][Full Text] [Related]
7. Pyrrolo[1,2-a]benzimidazole-based quinones and iminoquinones. The role of the 3-substituent on cytotoxicity.
Schulz WG; Islam I; Skibo EB
J Med Chem; 1995 Jan; 38(1):109-18. PubMed ID: 7837221
[TBL] [Abstract][Full Text] [Related]
8. First synthesis of an aziridinyl fused pyrrolo[1,2-a]benzimidazole and toxicity evaluation towards normal and breast cancer cell lines.
Bonham S; O'Donovan L; Carty MP; Aldabbagh F
Org Biomol Chem; 2011 Oct; 9(19):6700-6. PubMed ID: 21808774
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of topoisomerase II based on the benzodiimidazole and dipyrroloimidazobenzimidazole ring systems: controlling DT-diaphorase reductive inactivation with steric bulk.
Schulz WG; Skibo EB
J Med Chem; 2000 Feb; 43(4):629-38. PubMed ID: 10691689
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of C8-linked pyrrolo[2,1-c][1,4]benzodiazepine-benzimidazole conjugates with remarkable DNA-binding affinity.
Kamal A; Ramulu P; Srinivas O; Ramesh G; Kumar PP
Bioorg Med Chem Lett; 2004 Sep; 14(18):4791-4. PubMed ID: 15324909
[TBL] [Abstract][Full Text] [Related]
11. Benzimidazole condensed ring systems 10 (1). Synthesis and cytotoxic activity of some pyrido[1,2-a]benzimidazoles.
Badawey ES; Kappe T
Farmaco; 1995; 50(7-8):537-42. PubMed ID: 7669192
[TBL] [Abstract][Full Text] [Related]
12. Benzimidazole condensed ring systems. XI. Synthesis of some substituted cycloalkyl pyrido[1,2-a]benzimidazoles with anticipated antineoplastic activity.
Badawey EA; Kappe T
Eur J Med Chem; 1999; 34(7-8):663-7. PubMed ID: 11278052
[TBL] [Abstract][Full Text] [Related]
13. Benzimidazole condensed ring systems. XII. Synthesis and anticancer evaluation of certain pyrido[1,2-a]benzimidazole derivatives.
el-Hawash SA; Badawey el-S A; Kappe T
Pharmazie; 1999 May; 54(5):341-6. PubMed ID: 10368827
[TBL] [Abstract][Full Text] [Related]
14. Studies of pyrrolo[1,2-alpha]benzimidazolequinone DT-diaphorase substrate activity, topoisomerase II inhibition activity, and DNA reductive alkylation.
Skibo EB; Gordon S; Bess L; Boruah R; Heileman MJ
J Med Chem; 1997 Apr; 40(9):1327-39. PubMed ID: 9135030
[TBL] [Abstract][Full Text] [Related]
15. Evidence for DNA phosphate backbone alkylation and cleavage by pyrrolo[1,2-a]benzimidazoles: small molecules capable of causing base-pair-specific phosphodiester bond hydrolysis.
Schulz WG; Nieman RA; Skibo EB
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11854-8. PubMed ID: 8524862
[TBL] [Abstract][Full Text] [Related]
16. Design of highly active analogues of the pyrrolo[1,2-a]benzimidazole antitumor agents.
Craigo WA; LeSueur BW; Skibo EB
J Med Chem; 1999 Aug; 42(17):3324-33. PubMed ID: 10464019
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of anticancer benzoxazoles and benzimidazoles related to UK-1.
Kumar D; Jacob MR; Reynolds MB; Kerwin SM
Bioorg Med Chem; 2002 Dec; 10(12):3997-4004. PubMed ID: 12413851
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumour activity of trimethylsilylpropyl substituted benzimidazoles.
Lukevics E; Arsenyan P; Shestakova I; Domracheva I; Nesterova A; Pudova O
Eur J Med Chem; 2001 Jun; 36(6):507-15. PubMed ID: 11525841
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro antitumor activity of 2-alkyl, 2-aryl, and 2-piperazinyl benzimidazole-4,7-dione derivatives.
Ahn CM; Tak JA; Choi SJ
Arch Pharm Res; 2000 Aug; 23(4):288-301. PubMed ID: 10976573
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 6-aziridinylbenzimidazole derivatives and their in vitro antitumor activities.
Ahn CM; Kim SK; Han JL
Arch Pharm Res; 1998 Oct; 21(5):599-609. PubMed ID: 9875502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
